Work

38 Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent ovarian cancer: final results

Year: 2019

Type: article

Study design: Clinical Trial

Source: International Journal of Gynecological Cancer

DOI: 10.1136/ijgc-2019-igcs.38

Authors: R. Grisham, D. Giri, M. Henson, A. Iasonos, Q. Zhou, A. McDonnell, J. Girshman, R. O’Cearbhaill, D. Zamarin, C. Aghajanian

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2974816702

FWCI: 0.199

Cites:

Cited by: 2

Related to: 10